6-DIMETHYL-3-(2',3',5'-TRI-O-BENZOYL-BETA-D-RIBOFURANOSYL)-1,2,4-TRIAZOLO-[3,4-F]-[1,2,4]-TRIAZINE
Compound with spectra: 1 NMR
![6-DIMETHYL-3-(2',3',5'-TRI-O-BENZOYL-BETA-D-RIBOFURANOSYL)-1,2,4-TRIAZOLO-[3,4-F]-[1,2,4]-TRIAZINE](/api/compound/I2ivZzyK07D.png?ph=true&h=300&w=458 "6-DIMETHYL-3-(2',3',5'-TRI-O-BENZOYL-BETA-D-RIBOFURANOSYL)-1,2,4-TRIAZOLO-[3,4-F]-[1,2,4]-TRIAZINE")
| SpectraBase Compound ID | I2ivZzyK07D |
|---|---|
| InChI | InChI=1S/C32H28N6O7/c1-37(2)32-33-18-24-34-35-28(38(24)36-32)27-26(45-31(41)22-16-10-5-11-17-22)25(44-30(40)21-14-8-4-9-15-21)23(43-27)19-42-29(39)20-12-6-3-7-13-20/h3-18,23,25-27H,19H2,1-2H3/t23-,25-,26-,27-/m1/s1 |
| InChIKey | ZPRGPGBSAHHXGW-MIRJVGOZSA-N |
| Mol Weight | 608.6 g/mol |
| Molecular Formula | C32H28N6O7 |
| Exact Mass | 608.201947 g/mol |
| Enantiomer InChIKey | ZPRGPGBSAHHXGW-MNUOIFNESA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
3-(5'-O-TERT.-BUTYLDIPHENYLSILYL-2',3'-O-ISOPROPYLIDENE-BETA-D-RIBOFURANOSYL)-6-(METHYLSULFANYL)-IMIDAZO-[2,1-F]-[1,2,4]-TRIAZINE
3,5-BIS-[C-(2,3,4,6-TETRA-O-BENZOYL-BETA-D-GLUCOPYRANOSYL)]-1,2,4-OXADIAZOLE
Methyl endo-8-acetyl-2,7-dimethyltricyclo[5.2.2.0(1,5)]undec-5-ene-6-carboxylate
Ethyl 5-(benzo[d][1,3]dioxol-5-yl)-7-methyl-2,3-dioxo-3,5-dihydro-2H-thiazolo[3,2-a]pyrimidine-6-carboxylate
.alpha.-D-Glucopyranoside, 1,3,4,6-tetrakis-O-(2,2-dimethyl-1-oxopropyl)-.beta.-D-fructofuranosyl, 2,3,6-tris(2,2-dimethylpropanoate)
YZZDFZVDPCNACW-CHOYZELCSA-N
PTEROCARYANIN-C
1-(4-ethoxyphenyl)-5-methoxy-2-methyl-1H-benzo[g]indole-3-carboxylic acid
6-O-BENZOYL-SHANZHISIDE_METHYLESTER
17.beta.-Hydroxy-7-oxoandrost-5-en-3.beta.-yl acetate - 7-[O-methoxycarbonyl]oxime
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of C-ribosyl 1,2,4-triazolo[3,4-f ][1,2,4]triazines as inhibitors of adenosine and AMP deaminases | Journal of the Chemical Society, Perkin Transactions 1 | 1999 |